  **Abbreviations, acronyms & symbols**   
  --------------------------------------- -----------------------------------------------
  AAA                                     = Abdominal aortic aneurysm
  AOD                                     = Aortoiliac occlusive disease
  BMI                                     = Body mass index
  CAT                                     = Catalase
  DCF                                     = 2,7-dichlorofluorescein
  H~2~O~2~                                = Hydrogen peroxide
  ICU                                     = Intensive care unit
  LVEF                                    = Left ventricular ejection fraction
  NADPH                                   = Nicotinamide-adenine-dinucleotide-phosphate
  NO                                      = Nitric oxide
  NOS                                     = Nitric oxide synthase
  O~2~-                                   = Superoxide anion
  OH-                                     = Hydroxyl radical
  ONOO-                                   = Peroxynitrite
  ROS                                     = Reactive oxygen species
  SAS                                     = Severe aortoiliac stenosis
  SOD                                     = Superoxide dismutase
  TAO                                     = Total aortoiliac occlusion

INTRODUCTION
============

Aortoiliac occlusive disease (AOD) provoked by atherosclerosis is an important cause of morbidity and mortality worldwide, which begins at the aortic terminus and common iliac artery origins and slowly progresses proximally and distally over time, resulting in a severe aortoiliac stenosis (SAS) or in a total aortoiliac occlusion (TAO)^\[[@r1]\]^. Although advances in the endovascular techniques, aortobifemoral bypass is still the gold standard treatment for patients with SAS and TAO^\[[@r1],[@r2]\]^.

The cellular and molecular basis for atherosclerosis is complex and is not completely understood^\[[@r3]\]^. It is widely accepted that oxidative stress plays important role in the pathogenesis of atherosclerosis^\[[@r4]\]^. Oxidative stress is caused by an imbalance between the production of reactive oxygen species (ROS) and the antioxidant capacity of the biological system^\[[@r5]\]^. ROS such as superoxide anion (O~2~^-^), hydroxyl radical (OH^-^), and hydrogen peroxide (H~2~O~2~), are produced through different pathways, but the major source of ROS in the vasculature is nicotinamide-adenine-dinucleotide-phosphate (NADPH) oxidase^\[[@r5],[@r6]\]^. Superoxide dismutase (SOD) is the major cellular defense system to remove O~2~^-^ in vascular cells by converting O~2~^-^ into H~2~O~2~, while catalase (CAT) converts two molecules of H~2~O~2~ into water and oxygen^\[[@r7]\]^. Nitric oxide (NO) - synthetized by nitric oxide synthase (NOS) - is a multifactorial free radical that plays a key role in the physiological regulation of the cardiovascular system, and changes in its production and/or bioavailability follow or even precede diseases such as atherosclerosis^\[[@r8]\]^. Superoxide anion may react with NO to form peroxynitrite (ONOO^-^), resulting in an increased cellular damage^[@r7]^. Moreover, inactivation of NO by O~2~^-^ limits the NO bioavailability leading to increased vasoconstriction, as commonly observed in the progression of atherosclerosis^\[[@r7]\]^.

Some experimental studies have investigated the role of oxidative stress in the atherosclerosis process^\[[@r4],[@r9],[@r10]\]^, but research in human beings are rare^\[[@r11]\]^. In this study, we evaluated the role of oxidative stress in patients\'s aortas whith SAS and TAO submitted to aortobifemoral bypass. Thus, we proposed to compare the oxidative damage in different degrees of AOD in human beings.

METHODS
=======

The project was approved by the Research Ethics Committee of Santa Casa de Porto Alegre and all patients signed free and informed consent forms. We reviewed medical records for patients with SAS and TAO electively submitted to aortobifemoral bypass by the first author as previously described^\[[@r2]\]^.

All the patients were submitted to surgical procedure due to a limiting claudication or critical limb ischemia (rest pain and/or non-healing wound). Patients with acute aortoiliac occlusion, abdominal aortic aneurysm (AAA) thrombosis, and submitted to previous aortoiliac intervention (endovascular or open repair) were excluded. Data were collected on age, gender, comorbidities and clinical presentation for patients with SAS or TAO. Laboratory profiles and surgical data were also routinely collected. All the patients were submitted to computed tomography angiography to plan the surgical procedures.

Human specimens of infrarenal abdominal aorta were removed in the operating room during the proximal anastomosis of aortobifemoral bypasses. After removing the calcifications, the aortic samples were immediately stored at -70°C for further analysis of oxidative stress parameters. They were macerate in liquid nitrogen. After that, it was homogenized (KCl 150 mmol/L; phenyl-methyl-fluoro-sulfonyl 20 mmol/L, 1:100) in the Ultra-Turrax homogenizer. Posteriorly, it was performed a sonification with the Hielscher Ultrasound Technology device^\[[@r12]\]^.

ROS concentration was measured by DCFH-DA fluorescence emission (Sigma-Aldrich, USA). Dichlorofluorescein diacetate is membrane permeable and is rapidly oxidized to the highly fluorescent 2,7-dichlorofluorescein (DCF) in the presence of intracellular ROS. The samples were excited at 488 nm and emission was collected with a 525 nm long pass filter. It was expressed as nmols per milligram of protein^\[[@r13]\]^.

Measurement of NADPH oxidase activity was assayed with spectrophotometric method^\[[@r14]\]^. SOD activity, expressed as U/mg protein, was based on the inhibition of superoxide radical reaction with pyrogallol^\[[@r15]\]^. CAT activity was determined by following the decrease in 240 nm absorption of hydrogen peroxide (H~2~O~2~). It was expressed as nmoles/mg protein^\[[@r16]\]^. NO in aortic samples was examined by measuring the level of nitrite, an oxidative metabolite of endogenous NO, by using the Griess reagent, in which a chromophore with a strong absorbance at 542 nm is formed by reaction of nitrite with a mixture of naphthyletilenediamine (0.1%) and sulphanilamide (1%). The absorbance was measured in a spectrophotometer to give the nitrite concentration^\[[@r17]\]^. Protein was measured by the method of Lowry et al.^\[[@r18]\]^, using bovine serum albumin as standard.

Statistical Analysis
--------------------

All data are expressed as the mean ± standard deviation. Comparisons between two groups were performed by Fisher\'s exact test and statistical analysis for three groups included the ANOVA method followed by t test. A statistical significance was assumed to be α=5%.

RESULTS
=======

Twenty-six patients were divided into three groups: control group (n=10) formed by cadaveric organ donors (aged 22 to 51 years old); SAS group (n=9) formed by patients with SAS; and TAO group (n=7) formed by patients with chronic total aortoiliac occlusion. The clinical and surgical data are summarized in [Table 1](#t1){ref-type="table"}. In each group, there were 4 women. The mean age, body mass index (BMI), and left ventricular ejection fraction (LVEF) were similar between the SAS and TAO groups. In relation to surgical data, there was no perioperative death in both groups. The duration of the procedures, blood loss, and intensive care unit (ICU) stay as well as postoperative hospital stay were also similar between the SAS and TAO groups ([Table 1](#t1){ref-type="table"}).

###### 

Clinical characteristics and surgical data of patients with severe aortoiliac stenosis (SAS) and totally aortoiliac occlusion (TAO) submitted to aortobifemoral bypass.

  **Characteristics**                 **SAS group (n=9)**   **TAO group (n=7)**   **P values**
  ----------------------------------- --------------------- --------------------- --------------
  Mean age (years)                    57.7±5.86             55.1±5.91             0.42
  Women n (%)                         4 (44.5)              4 (57.1)              1.00
  Tobacco use (%)                     9 (100)               7 (100)               1.00
  Hypertension (%)                    8 (88.9)              5 (71.4)              0.53
  Hyperlipidemia (%)                  3 (33.4)              2 (28.6)              1.00
  Diabetes (%)                        2 (22.3)              \-                    0.47
  BMI (kg/m^2^)                       25.8±3.25             21.8±4.33             0.13
  LVEF (%)                            60±2.67               67.5±8.01             0.06
  Systolic pressure (mmHg)            131.14±9.96           129.3±14.24           0.79
  Diastolic pressure (mmHg)           60.7±8.3              71.7±15.7             0.19
  Creatinine (mg/dL)                  0.92±0.14             0.94±0.08             0.88
  Perioperative death                 0                     0                     1.00
  Duration of procedures (minutes)    269.2±54.34           228±44.9              0.25
  Blood loss (mL)                     637.5±316.9           614.3±203.3           0.87
  Median postoperative days (range)   10.5 (7-14)           11 (6-19)             0.56
  Median ITU stay in hours (range)    46 (28-72)            40 (30-58)            0.17
  Lower preoperative ABI              0.44±0.13             0.39±0.08             0.48
  Postoperative ABI                   0.78±0.12             0.84±0.17             0.47

ABI=ankle-brachial index; BMI=body mass index; LVEF=left ventricular ejection fraction

The aortic ROS levels were significantly higher in the SAS and TAO groups when compared to the control group (*P*\<0.05). Patients with TAO demonstrated higher levels of ROS (48.3±10.22 pmol/mg protein) when compared to the SAS group (33.02±4.54 pmol/mg protein; *P*\<0.05) ([Figure 1](#f1){ref-type="fig"}).

Fig. 1Levels of reactive oxygen species (ROS) on human aortas of patients with severe aortoiliac occlusive stenosis (SAS) and with total aortoiliac occlusion (TAO). Values are expressed in mean and the brackets represent interval of confidence of 95%. ANOVA followed test t. \*P\<0.05 when compared to control group; and ^\#^P\<0.05 when compared to SAS group.

Measurement of NADPH oxidase activity demonstrated that TAO group had an increment when compared to control group ([Figure 2](#f2){ref-type="fig"}). Moreover, there was no difference in the NADPH oxidase activity between SAS and others groups (*P*\>0.05).

Fig. 2NADPH oxidase activity on human aortas of patients with severe aortoiliac occlusive stenosis (SAS) and with total aortoiliac occlusion (TAO). Values are expressed in mean and the brackets represent interval of confidence of 95%. ANOVA followed test t. \*P\<0.05 when compared to control group..

It was observed an increase of SOD activity in the SAS and TAO groups when compared to the control group (*P*\<0.05) ([Figure 3](#f3){ref-type="fig"}). However, there was no statistical difference between SAS and TAO groups. There was a significant increase of CAT activity in the SAS and TAO groups when compared to the control group. Furthermore, CAT activity in aortas from patients with SAS (60.2±9.5 pmol/mg protein) was statistically higher in comparing to the TAO group (44.74±7 pmol/mg protein; *P*\<0.05) ([Figure 4](#f4){ref-type="fig"}).

Fig. 3Superoxide dismutase (SOD) activity on human aortas of patients with severe aortoiliac occlusive stenosis (SAS) and with total aortoiliac occlusion (TAO). Values are expressed in mean and the brackets represent interval of confidence of 95%. ANOVA followed test t. \*P\<0.05 when compared to control group. Fig. 4Catalase (CAT) activity on human aortas of patients with severe aortoiliac occlusive stenosis (SAS) and with total aortoiliac occlusion (TAO). Values are expressed in mean and the brackets represent interval of confidence of 95%. ANOVA followed test t. \*P\<0.05 when compared to control group; ^\#^P\<0.05 when compared to TAO group.

Nitrite levels were significantly lower in the aortic samples of patients with SAS when compared to the other groups (*P*\<0.05). Furthermore, there was no difference in the nitrite levels between TAO and the control group (*P*\>0.05) ([Figure 5](#f5){ref-type="fig"}).

Fig. 5Nitrite levels on human aortas of patients with severe aortoiliac occlusive stenosis (SAS) and with total aortoiliac occlusion (TAO). Values are expressed in mean and the brackets represent interval of confidence of 95%. ANOVA followed test t. \*P\<0.05 when compared to SAS group.

DISCUSSION
==========

Advanced AOD tends to occur in relatively young patients who have a history of tobacco abuse. Basically, patients with SAS and TAO are treated by the aortobifemoral bypass and the surgical results in these patients seems to be similar^\[[@r2],[@r19]\]^.

The major finding of our study was to demonstrate the role of oxidative stress in the atherosclerosis in patients with different degrees of AOD. Our results demonstrated that ROS levels were progressively higher as more severe as the AOD was. This way, patients with SAS or TAO had a higher ROS levels on their aorta samples; and the TAO group demonstrated a more elevated of ROS levels than SAS group. The role of ROS in the onset and progression of atherosclerotic damage in aortas has been described in animal models of different illnesses, being the ROS important mediators in the signaling pathways of inflammation and atherogenesis^\[[@r4],[@r5]\]^. In atherosclerosis, ROS production can increment endothelial dysfunction, vascular smooth muscle cells proliferation and apoptosis, and inflammatory response^\[[@r20]\]^. Another markers of oxidative stress, such as levels of O~2~^-^, thiobarbituric acid and conjugated dienes were also evaluated in aortic samples of patients with atherosclerosis^\[[@r21]\]^.

Xiong et al.^\[[@r22]\]^ demonstrated that the earliest changes in an experimental model of AAA were associated with the local production of ROS. In the study of Miller et al.^\[[@r21]\]^, it was measured levels of O~2~^-^ and lipid peroxidation products in segments of AAA and in adjacent nonaneurysmal aortic tissue removed from patients undergoing elective AAA repair. The results indicated that levels of ROS are locally increased in AAA, partially because of NADPH oxidase activity, and lead to marked increases in oxidative stress. There are evidences that NADPH oxidase expression and activity are upregulated in atherosclerosis^\[[@r23]\]^. Analysis of non-atherosclerotic *versus* atherosclerotic human carotid arteries demonstrated a higher level of NADPH oxidase expression in atherosclerotic arteries^\[[@r23]\]^. We also observed an increase of NADPH oxidase activity in patients with TAO when compared to the control group. Haidari et al.^\[[@r3]\]^ observed an increase of oxidative stress in atherosclerosis-predisposed regions of the normal C57BL/6 mouse aorta, implicating NADPH oxidase as a possible contributing enzyme.

The imbalance between oxidants and antioxidants in favor of the former ones plays a significant role in the pathogenesis of atherosclerotic vascular disease^\[[@r6]\]^. Thus, knowledge of the activity of antioxidants enzymes is very important. Under normal conditions, SOD is the first line of defense against oxidative stress^\[[@r5]\]^. Dubick et al.^\[[@r24]\]^ demonstrated a lower activity of SOD in human aortic samples of patients with AAA and AOD in comparing to non-atherosclerotic organ donors. In another work, the same group of authors also compared the SOD activity between aortic specimens of patients with aneurysmal and occlusive disease. These authors evidenced a reduced SOD activity in occlusive (n=14) compared to aneurysmal (n=29) group^\[[@r25]\]^. In contrast, our study showed a significant increase of SOD activity in the SAS and TAO samples when compared to the control group, maybe because a compensative phenomenon to minimize oxidative stress. Furthermore, the role of oxidative stress in different aortopathies was evaluated by Soto et al.^\[[@r5]\]^. In this study, there was an increase in SOD activity in aorta specimens of patients with hypertension, Marfan and Turner\'s syndromes^\[[@r5]\]^.

Catalase is another important antioxidant enzyme, which is found in the liver, kidney, and aorta. Catalase uses two H~2~O~2~ molecules to break them into O~2~^-^; one acts as a reducing agent and the other as an oxidant agent. Overexpression of CAT prevents the stimulation of ROS and can prevent AAA formation in experimental setting^\[[@r26]\]^. Moreover, a diminished CAT expression and activity were observed in polymorphonuclear neutrophils in patients with AAA^\[[@r27]\]^. Soto et al.^\[[@r5]\]^ also showed that CAT activity increased in the patients with different aortopathies. Our results corroborate these findings that the increase of CAT activity in SAS and TAO groups may be due to overproduction of H~2~O~2~ in the aorta from these patients.

NO is usually quoted for its vasodilating properties and protective role in many vascular diseases and previous reports have indicated that decreased activity and production of NO play an important role in vascular disease^\[[@r11]\]^. Endothelial dysfunction and downregulated NO would contribute to the stiffness, reduced distensibility, and aortic complications such as AOD^\[[@r5]\]^. Our results showed a decrease of nitrite levels in SAS group may be due to endothelium dysfunction. Moreover, we did not observe an increase in nitrite levels in patients with TAO and this can be explained at least in part because of the higher levels of ROS which could increase the nitrite levels by inducible NOS activation, an enzyme which produces high quantities of NO, resulting in more oxidative stress^\[[@r11],[@r21]\]^. Taking together, the higher levels of ROS and nitrite could facilitate intravascular thrombus formation by reducing the antiplatelets effects of NO^\[[@r28]\]^. Then, this aortic thrombus can provoke an inflammatory response in the aortic wall and can also limit the oxygen supply to endothelium resulting in increasing of NO production^\[[@r29]\]^. Liao et al.^\[[@r11]\]^ founded an overexpression of NOS which was positively correlated with the degree of inflammation in the aortic wall in patients with AAA.

The major limitation of this study is the small size of patients and aortic samples, preventing some correlation with clinical and angiographic findings. However, previous studies performed with human aortic samples have also been described with small number of samples and have obtained aortas from autopsy or organ donor patients as control group^\[[@r5],[@r11],[@r21],[@r24],[@r25]\]^. To our knowledge, this is the first study in which human aortic segments of patients with different degrees of AOD were directly compared.

CONCLUSION
==========

Our study on human aortic samples showed that oxidative stress seems to be related with the degree of AOD and the increase of antioxidant enzymes (SOD and CAT) activities may be due to a compensative phenomenon. Moreover, nitrite overproduction occurred in patients with chronic total aortic occlusion (TAO group) while its reduction was observed in severe aortoiliac stenosis (SAS group). Although antioxidant therapies did not have a consistent effect in some clinical trials for prevention atherosclerosis complications^\[[@r30]\]^, this preliminary study offer us a more comprehensive knowledge about the role of oxidative stress in atherosclerotic aortas in human beings.
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